myeloid leukemia trang 3 tải miễn phí từ TAILIEUCHUNG

"myeloid leukemia" trang 3 - tải miễn phí từ Tailieuchung

Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival

Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival

12 42 0

Long-term outcome of childhood acute myeloid leukemia at Hue Central Hospital

Long-term outcome of childhood acute myeloid leukemia at Hue Central Hospital

6 81 0

Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: A case report and a brief review of the literature

Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: A case report and a brief review of the literature

6 81 0

Transcriptome profiling reveals the high incidence of hnRNPA1 exon 8 inclusion in chronic myeloid leukemia

Transcriptome profiling reveals the high incidence of hnRNPA1 exon 8 inclusion in chronic myeloid leukemia

10 41 0

Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia

Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia

10 90 0

FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/ AKT1/NFκB pathway

FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/ AKT1/NFκB pathway

11 31 0

Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients

Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients

11 40 0

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

8 67 0

The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: A systematicreview and meta-analysis

The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: A systematicreview and meta-analysis

11 80 0

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients

12 84 0

Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: A prospective, longitudinal, single center study

Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: A prospective, longitudinal, single center study

11 75 0

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells

13 69 1

The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun

The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun

9 24 1

A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia

A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia

17 47 1

Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia

Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia

8 42 1

A rare BCR-ABL1 transcript in Philadelphiapositive acute myeloid leukemia: Case report and literature review

A rare BCR-ABL1 transcript in Philadelphiapositive acute myeloid leukemia: Case report and literature review

6 59 1

Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia

Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia

10 55 1

The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: A population-based study

The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: A population-based study

12 21 1

Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia

Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia

12 47 1

Finding the right BCR-ABL1 tyrosine kinase inhibitor: A case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib

Finding the right BCR-ABL1 tyrosine kinase inhibitor: A case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib

5 49 1

Đầu
1
2
[ 3 ]
4
5
6
7
8
9
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.